Anthony Vendetti
Stock Analyst at Maxim Group
(4.44)
# 318
Out of 4,911 analysts
80
Total ratings
30.56%
Success rate
57.12%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSF Laird Superfood | Initiates: Buy | $12 | $7.40 | +62.16% | 1 | Jun 30, 2025 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $6 → $3 | $0.70 | +329.06% | 4 | May 21, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $100 → $225 | $95.02 | +136.79% | 5 | May 20, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $5.54 | +80.51% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.88 | +165.96% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $1.39 | +259.71% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.33 | - | 2 | Apr 1, 2025 | |
| NXL Nexalin Technology | Upgrades: Buy | $5 | $1.16 | +331.03% | 3 | Mar 24, 2025 | |
| SSKN STRATA Skin Sciences | Initiates: Buy | $6 | $1.96 | +206.12% | 1 | Feb 27, 2025 | |
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $7.58 | +58.31% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.47 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $1.06 | +654.72% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.15 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $46.64 | +7.20% | 7 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.48 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $3.15 | +1,804.76% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $9.03 | +10.74% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.07 | +367.29% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.95 | +2,426.32% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.36 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $2.11 | -5.21% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.77 | +16,114.81% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.44 | +1,490.91% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $34.42 | -27.37% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.58 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $2.61 | +133,999.62% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $3.08 | +62.34% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.33 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.07 | +180.37% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.89 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $5.05 | +2,376,137.62% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $46.84 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.83 | +86,334.57% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.49 | -52.34% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.99 | - | 1 | May 31, 2016 |
Laird Superfood
Jun 30, 2025
Initiates: Buy
Price Target: $12
Current: $7.40
Upside: +62.16%
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.70
Upside: +329.06%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $95.02
Upside: +136.79%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $5.54
Upside: +80.51%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.88
Upside: +165.96%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.39
Upside: +259.71%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
STRATA Skin Sciences
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $1.96
Upside: +206.12%
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $7.58
Upside: +58.31%
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.47
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.06
Upside: +654.72%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $8.15
Upside: -
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $46.64
Upside: +7.20%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.48
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $3.15
Upside: +1,804.76%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $9.03
Upside: +10.74%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $1.07
Upside: +367.29%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.95
Upside: +2,426.32%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.36
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $2.11
Upside: -5.21%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.77
Upside: +16,114.81%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.44
Upside: +1,490.91%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $34.42
Upside: -27.37%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.58
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $2.61
Upside: +133,999.62%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $3.08
Upside: +62.34%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.33
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $14.89
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $5.05
Upside: +2,376,137.62%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $46.84
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.83
Upside: +86,334.57%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.49
Upside: -52.34%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $14.99
Upside: -